These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 15102987)

  • 1. Dobutamine-induced myoclonia in severe renal failure.
    Wierre L; Decaudin B; Barsumau J; Vairon MX; Horrent S; Odou P; Azar R
    Nephrol Dial Transplant; 2004 May; 19(5):1336-7. PubMed ID: 15102987
    [No Abstract]   [Full Text] [Related]  

  • 2. Case reports of dobutamine-induced myoclonia in severe renal failure: potential of emerging pharmacovigilance technologies.
    Hauben M; Reich L
    Nephrol Dial Transplant; 2005 Feb; 20(2):471-2. PubMed ID: 15673706
    [No Abstract]   [Full Text] [Related]  

  • 3. Transient dobutamine-mediated pulsus alternans.
    Kahn JH; Starling MR; Supiano MA
    Can J Cardiol; 2001 Feb; 17(2):203-5. PubMed ID: 11223491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of intermittent, long-term, concomitant dobutamine and levosimendan infusions in severe heart failure refractory to dobutamine alone.
    Nanas JN; Papazoglou P; Tsagalou EP; Ntalianis A; Tsolakis E; Terrovitis JV; Kanakakis J; Nanas SN; Alexopoulos GP; Anastasiou-Nana MI
    Am J Cardiol; 2005 Mar; 95(6):768-71. PubMed ID: 15757608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dobutamine-induced eosinophilia.
    El-Sayed OM; Abdelfattah RR; Barcelona R; Leier CV
    Am J Cardiol; 2004 Apr; 93(8):1078-9. PubMed ID: 15081466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Catecholamines use in patients with heart failure].
    Iino K; Ito H
    Nihon Rinsho; 2007 May; 65 Suppl 5():30-3. PubMed ID: 17571362
    [No Abstract]   [Full Text] [Related]  

  • 7. Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure.
    Cohen-Solal A; Logeart D; Huang B; Cai D; Nieminen MS; Mebazaa A
    J Am Coll Cardiol; 2009 Jun; 53(25):2343-8. PubMed ID: 19539144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dobutamine-related asthma in a patient awaiting cardiac transplantation: the eosinophilic dilemma.
    Aranda JM; Woo G; Pauly DF; Rodriguez E; Hill JA; Schofield RS
    J Heart Lung Transplant; 2004 Feb; 23(2):260-1. PubMed ID: 14761776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiographic documented dobutamine induced coronary spasm successfully treated by stenting.
    Bonvini RF; Hendiri T; Sigwart U
    Heart; 2006 Aug; 92(8):1054. PubMed ID: 16844854
    [No Abstract]   [Full Text] [Related]  

  • 10. A Dobutamine paradox: eosinophilic myocarditis in the explanted heart of a 9-year-old girl undergoing cardiac transplantation.
    Fenton M; Burch M; Sebire N
    Cardiol Young; 2005 Oct; 15(5):520-2. PubMed ID: 16164793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dobutamine-induced fever and isolated eosinophilic myocarditis in a 66-year-old male awaiting heart transplantation: a case report.
    Lee CC; Luthringer DJ; Czer LS
    Transplant Proc; 2014 Sep; 46(7):2464-6. PubMed ID: 25242803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.
    Arnold LM; Crouch MA; Carroll NV; Oinonen MJ
    Pharmacotherapy; 2006 Aug; 26(8):1078-85. PubMed ID: 16863484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myoclonus associated with continuous dobutamine infusion in a patient with end-stage renal disease.
    Boord A; Benson B
    Am J Health Syst Pharm; 2007 Nov; 64(21):2241-3. PubMed ID: 17959575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dobutamine: too dangerous for "routine" administration?
    Butterworth J
    Anesthesiology; 2008 Jun; 108(6):973-4. PubMed ID: 18497594
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognosis on chronic dobutamine or milrinone infusions for stage D heart failure.
    Gorodeski EZ; Chu EC; Reese JR; Shishehbor MH; Hsich E; Starling RC
    Circ Heart Fail; 2009 Jul; 2(4):320-4. PubMed ID: 19808355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial fibrillation in dobutamine stress echocardiography.
    Carasso S; Sandach A; Kuperstein R; Schwammenthal E; Glikson M; Luria D; Guetta V; Shechter M; Eldar M; Feinberg MS
    Int J Cardiol; 2006 Jul; 111(1):53-8. PubMed ID: 16054714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dobutamine therapy at home under the guidance of a nurse practitioner, either as a bridge to cardiac transplantation or as destination therapy in severe heart failure].
    Brügemann J; de Jonge-Weber AT; Rienstra M; van den Broek SA; Zijlstra F; van Veldhuisen DJ
    Ned Tijdschr Geneeskd; 2007 Nov; 151(44):2460-5. PubMed ID: 18064867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure.
    Adamopoulos S; Parissis JT; Iliodromitis EK; Paraskevaidis I; Tsiapras D; Farmakis D; Karatzas D; Gheorghiade M; Filippatos GS; Kremastinos DT
    Am J Cardiol; 2006 Jul; 98(1):102-6. PubMed ID: 16784930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Myocardial bridging of the left anterior descending coronary artery and dobutamine-induced left ventricular outflow tract gradient -- a case report].
    Kuliczkowski W; Goździk A; Protasiewicz M; Negrusz-Kawecka M; Mazurek W
    Kardiol Pol; 2006 Jan; 64(1):63-7; discussion 67. PubMed ID: 16444635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of nesiritide (human b-type natriuretic peptide) and dobutamine on heart rate variability in decompensated heart failure.
    Aronson D; Burger AJ
    Am Heart J; 2004 Nov; 148(5):e16. PubMed ID: 15523294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.